Resumos

Índice de Palavras-chave
 

Voltar



&

Topo


β-LACTAMASE     [16-1]


1

Topo


16S.     [115-1]


A

Topo


AEDES AEGYPTI     [8-2]

ALVEOLI NECROSIS     [41-1]

ANTIBACTERIAL ACTIVITY     [57-1]

ANTIBACTERIAL AGENTS     [28-1]

ANTIBACTERIAL SUSCEPTIBILITY     [61-1]

ANTIMICROBIAL ACTIVITY     [62-1]

ANTIMICROBIAL RESISTANCE     [59-1]

ANTIMICROBIAL SUSCEPTIBILITY     [21-1]

AUTOMATED METHOD     [132-1]


B

Topo


BACTEREMIA     [132-1]

BACTERIA     [96-1], [99-2]

BACTERIAL INFECTIONS     [115-1]

BACTERIAL MENINGITIS     [75-1]

BACTERIAL RESISTANCE     [26-2], [33-1]

BETA-HEMOLISE     [41-1]

BETA-LACTAMASES     [26-1]

BIOFILM     [21-1], [28-1], [64-2], [96-1]

BIOFILMS     [34-1], [102-1]

BLANDM-1     [129-1]

BLOOD CULTURE     [130-1]

BLOODSTREAM     [61-1], [130-2]

BLOODSTREAM INFECTION     [130-1]

BOVINE     [127-3]

BUNDLE     [22-1]


C

Topo


CANDIDA ALBICANS     [64-2], [102-1]

CARBAPENEMASE     [14-1], [31-2]

CARBAPENEMASE; ; KLE     [14-2]

CARBAPENEMASES     [23-2]

CATIONIC ANTIMICROBIAL PEPTIDES     [34-1]

CELL CULTURE     [34-1], [36-1]

CHIKUNGUNYA     [8-3]

CHLAMYDIA PNEUMONIAE     [37-2]

CHLAMYDIA TRACHOMATIS     [37-1]

CLADINA DENDROIDES     [128-1]

CLINICAL     [8-3]

COLISTIN     [23-2]

COLONIZATION     [39-1]

COMPLEX WOUNDS.     [46-1]

CONFOCAL MICROSCOPY     [34-1]

CONVENTIONAL PCR     [39-1]

COST     [22-1]

CROSS-CONTAMINATION     [32-1]

CRYPTOCOCCAL MENINGITIS     [52-1]

CURCUMIN     [102-1]


D

Topo


DECONTAMINATION TECHNIQUES     [32-1]

DENGUE     [8-3]

DENGUE VIRUS     [8-2]

DENTAL BIOFILM     [123-1]

DENTAL CARIES     [36-1], [123-1]

DESCRITIVE EPIDEMIOLOGY     [56-1]

DIABETIC FOOT WOUND     [62-1]

DIAGNOSTIC     [8-3], [37-1], [37-2]

DIFFUSION AGAR     [128-2]

DISK DIFFUSION TEST     [128-1]

DOG     [63-1]

DRUG-RESISTANT     [29-1]


E

Topo


E-TEST     [132-1]

E. FAECALIS     [23-1]

EFFLUX PUMP     [16-1]

ENTEROAGGREGATIVE ESCHERICHIA COLI     [21-1]

ENTEROBACTER SPP.     [31-2]

ENTEROBACTERIACEAE     [30-1], [129-1]

ENTEROBACTERIAS     [26-1], [26-2]

ENVIRONMENT     [30-1]

EPIDEMIOLOGICAL     [127-3]

EPIDEMIOLOGY     [8-2], [65-2]

ESBL     [30-1], [31-2], [42-1]

ESCHERICHIA COLI     [99-1]

EXTRACELLULAR MATRIX     [123-1]


F

Topo


FECAL MICROBIOTA     [35-1]

FEMA     [39-1]


H

Topo


HEALING     [99-2]

HEALTHCARE CENTER PATIENT.     [46-1]

HIGH-RESOLUTION MELTING     [33-1]

HIV     [52-1], [65-2]


I

Topo


ICU     [30-1]

IMLSB     [11-1]

INFECTION     [33-1], [42-1]

INTENSIVE CARE UNIT     [11-1], [22-1]


K

Topo


KERATINOCYTES     [64-2]

KLEBSIELLA PNEUMONIAE     [14-1], [130-2]

KLEBSIELLA PNEUMONIAE;     [14-2]

KPC     [14-1], [14-2], [130-2]


L

Topo


LACTOBACILLUS SP     [35-1]

LEMON GRASS     [99-1]

LICHEN EXTRACTS     [128-1]

LUKS-F     [39-1]


M

Topo


MALDI-TOF     [59-1]

MANHEIMIOSIS     [41-1]

MBIC     [21-1]

MECA     [39-1]

MECHANICAL VENTILATION;     [42-1]

METHICILLIN     [33-1]

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUR     [102-1]

MIC     [57-1]

MICROBIAL SENSITIVITY TESTS     [34-1], [36-1]

MICROBIOLOGICAL     [127-3]

MICROBIOLOGICAL CONTAMINATION     [32-1]

MINIMAL INHIBITORY CONCENTRATION     [10-1]

MOLECULAR DIAGNOSIS     [75-1]

MORTALITY     [22-1]

MRSA     [11-1]

MULTIDRUG RESISTANCE     [63-1]

MULTIDRUG-RESISTANT BACTERIA     [10-1], [10-2]

MULTIRESISTANT     [23-2], [65-1]

MUSA     [99-2]

MYCOBACTERIUM PHLEI     [128-2]

MYCOBACTERIUM TUBERCULOSIS     [17-2], [17-3], [29-1]


N

Topo


NANOPARTICLES     [57-1]

NITRATE REDUCTION METHOD     [29-1]

NOSOCOMIAL INFECTION     [14-1], [14-2]

NOSOCOMIAL OUTBREAK     [14-1], [14-2]


O

Topo


OBLIGATE ANAEROBES     [59-1]

ORIGANUM VULGARE     [10-1], [10-2]


P

Topo


PEG-LID     [21-1]

PENITENTIARY SYSTEM     [17-2]

PEPTIDES     [36-1]

PFGE     [23-2]

PHAGE DISPLAY     [37-1], [37-2]

PHOTODYNAMIC THERAPY     [96-1]

PHYTOTHERAPY     [99-2]

PLANTS EXTRACTS     [128-2]

PLASMID     [129-1]

PLASMIDS     [75-1]

PMQR     [31-2]

PREVALENCE     [17-2]

PSEUDOMONAS     [16-1]


R

Topo


RAPID DIAGNOSIS     [130-1]

REAL TIME PCR     [75-1]

REAL TIME POLYMERASE CHAIN REACTION     [115-1]

REAL-TIME PCR     [17-2], [17-3]

RELAPSED AND REFRACTORY     [52-1]

RESISTANCE     [16-1], [30-1], [65-1]

RESISTANCE;     [42-1]

RNA     [115-1]

ROBIN SEQUENCE     [35-1]

RUMINANT     [41-1]


S

Topo


S. AUREUS     [23-1]

SALMONELLA     [127-3]

SALMONELLA TYPHI     [61-1]

SANTO ANDRE     [56-1]

SEPSIS     [115-1]

SEROVARES     [127-3]

SOLIDAGO MICROGLOSSA     [62-1]

SPONGE     [32-1]

STAPHYLOCOCCUS AUREUS     [11-1], [33-1], [64-2], [99-1]

STAPHYLOCOCCUS PSEUDINTERMEDIUS     [63-1]

STAPHYLOCOCCUS SAPROPHYTICUS     [28-1]

STAPHYLOCOCCUS SPP.,     [132-1]

STREPTOCOCCUS MUTANS     [123-1]

SUSCEPTIBILITY PROFILE     [26-1]

SUSCEPTIBILITY PROFILE.     [46-1]

SUSCEPTIBILITY TO ANTIFUNGAL AGENTS     [52-1]

SYNERGISM     [10-2]


T

Topo


TEDIZOLID     [23-1]

TIGECYCLINE     [23-2]

TN3000     [129-1]

TOXICITY     [64-2]

TUBERCULOSIS     [17-2], [17-3], [29-1], [56-1], [65-1], [65-2]


U

Topo


URINARY TRACT INFECTION     [26-2], [28-1]

UTI     [26-1]


V

Topo


VANCOMYCIN     [132-1]

VENTILATOR-ASSOCIATED PNEUMONIA     [22-1]


W

Topo


WOUND     [99-2]


Y

Topo


YEAST     [96-1]